Stay updated on Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Sign up to get notified when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.

Latest updates to the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page
- Check5 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6, indicating a minor page version increment. This update reflects a backend/formatting change rather than a modification to the study details or visible content.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe footer revision label was updated from v3.6.4 to v3.6.5, signaling a software update. This change does not modify the study details or how the page presents information.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.6.4 was released, replacing the previous v3.6.3 version. This reflects a minor maintenance update to the page build rather than any new or altered content on the study details.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.6.3 is now displayed, replacing the previous v3.6.2. This indicates a minor page update; no study content or essential details appear to be changed based on the available data.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This appears to be a maintenance update and does not change study details or participant information.SummaryDifference0.1%

- Check84 days agoChange DetectedRecruitment status on the study page now indicates no participants are being enrolled. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment labeling along with a new revision tag.SummaryDifference0.5%

Stay in the know with updates to Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.